The PANBioRA testing device will contribute towards minimising the adverse reactions after the implantation of biomaterials. After two years of intense research, a first prototype integrating different testing systems was presented to the project consortium. This first prototype version is composed of a cytotoxicity integrated system including a machine-learning-based image analyser. Further elements such as an organ-on-chip system testing module will be integrated in the course of the project.
Learn more about the project's latest developments and gain insights into the first prototype verison of the PANBioRA device.
The full press release is available here.